Evgen Pharma Share Discussion Threads

[teddy boy1] 12/6/2018 15:52

Despite trading being very slow and no adverse news ,the share price is still being worked down by the market makers (for no good reason!) Expect this trend to be reversed tomorrow when the M Ms try to create themselves a bit of business by upping the price to set off a spate of buying.Just wait and see!

[nico115] 12/6/2018 15:27

Where's Berney?He is the pump and dump crew on Twitter Pumped this every day for weeks and now gone awolTrust him at your peril

[teddy boy1] 12/6/2018 12:27

Tomorrow being the 13th June we shall be getting the interim financial results but ,more importantly, this will be followed later in the morning by an anaylists briefing session. I have no doubt that Evgen will be eager to elaborate on the trial update and to reinforce the fact that the results so far have been "highly encouraging" Hence I am expecting a nice spike in the share price tomorrow ! Don't miss out! DYOR>

[teddy boy1] 12/6/2018 11:48

Still a decent amount of buying going on so it seems that there are many who have "kept the faith", which in the light of the trial update is not too surprising.

It is clear to me that the share price was stepped down yesterday by the market makers in order to try and sow doubt so that they could accumulate some more of these tightly held shares.

Within the next day or two the process will be reversed. The share price will be stepped up at the beginning of the day and this will attract buyers. How do I know.?- because this process is being repeated again and again on shares such as this.!


The bottom line is that the update reads very well and gives encouragement to the company to plough ahead to demonstrate to all concerned that they have a winner on their hands.This is ,of course , assuming that they do not get taken out before very long by one of the big pharmas who will be able to see that this treatment definitely "has legs" and consequently could, in time, be a useful and profitable addition to their portfolio WATCH THIS SPACE!

[nobbygnome] 11/6/2018 20:07

>> tb

Yes we may well see some upward movement tomorrow. However, ultimately I am prepared to wait for the real valuation we should get when the complete trial reads out at the end of this year. The current market cap is mad for a company with a very promising drug for multiple indications.

Nobby

[teddy boy1] 11/6/2018 19:57

It is pleasing to see that Northland Capital having seen the trial update,are still of the opinion that the share price target should remain unchanged at 113P.

In my opinion there has been a certain amount of share price manipulation to-day as there has been more buying than selling. If past experience is anything to go by, I will be very surprised if the price does not show a nice "correction" tomorrow.

Things are still on course for Evgen although it will be another 6 months before this has been one hundred per cent proved. In the meantime I am still more that happy to have this share in my portfolio!

[pdt] 11/6/2018 19:40

It will be interesting to see what the results are like split between the 3 cohorts. To get a meaningful result we will need to wait until the full 60 patients have completed the trial. It may be that one performs better than the other two.

Disappointing to see the price fall but I am happy to wait.

[nobbygnome] 11/6/2018 16:20

These are patients on palliative care so are terminal. There are few treatment options left for them.

[wins73] 11/6/2018 15:31

The buys are more than sells but price is down. MM are smart, encouraging release is stock so they will have availability to sell!

[nico115] 11/6/2018 12:50

Berney is v quiet!! Lol

[supernumerary] 11/6/2018 12:13

Of course they're likely to reach the end of their treatment options eventually, but the indications are that it's not yet for these patients.

The share price went from about 10p to about 25p in just a few weeks. It's clear from the tone on here that some people were expecting more from this readout, and the share price action today reflects that. To say that others in the space are worth a lot more means nothing - that's true of pretty much every company on AIM.

[pdt] 11/6/2018 11:26

Supernumerary - all current treatments for advanced breast cancer eventually meet resistance.

This is a £20m market cap company. What weight of expectation in the share price? Others in this space are multi billion cap companies.

[supernumerary] 11/6/2018 10:54

PDT - I don't think there's any indication that these patients have 'run out of treatment options' is there? The doc himself says: 'instead of switching to an alternative regimen', so clearly there are other possibilities for them.

Overall, not bad, but didn't live up to the weight of expectation in the share price would be my view. No CRs, no PRs, 4 SDs and 4 short-term SDs is certainly not going to set the world alight, but given that the drug is cheap and safe, it could form a useful additional therapy option for these patients.

It's a pity that without a control arm, there won't be much they can say about OS.

[pdt] 11/6/2018 10:41

If these results are replicated at the full read out it is a great treatment option after CDK 4/6 resistance. The market opportunity is in the billions of dollars. I would not be surprised to see a licence deal struck over the next few months.

[volsung] 11/6/2018 10:29

Looks like a decent time to buy in here. So I have

[teddy boy1] 11/6/2018 09:43

LIGHTHOUSE share price up (13 per cent) as predicted!

[nobbygnome] 11/6/2018 08:53

Clearly that is how it works on Aim and more than a week is a long time to hold shares for most people here!

However, the full results will be towards the end of this year so for the patient not long to wait!

Nobby

[douglas macarthur] 11/6/2018 08:23

Yes but buy on rumour and sell on news. That's how it works.

Come back when the hot money is gone.

rinse and repeat. That's my opinion

[nobbygnome] 11/6/2018 08:22

Aim is mad! The company is definitely worth more today than yesterday yet down we go.

C'est la vie.....

[purple11] 11/6/2018 08:05

no interest atm

[nobbygnome] 11/6/2018 07:55

And more than 20% had clinically meaningful responses which didn't last 6 months....

[timbo003] 11/6/2018 07:51

This looks like a very satisfactory update to me. Patients in this study have terminal cancer and the drug appears to have benefited 4 out of 20 patients so far. Judging from the KOL's comments this is clinically meaningful, so it bodes well for the final readout.